Thermo Fisher Scientific QuantStudio 5 Real-Time PCR System
Thermo Fisher Scientific has launched the Applied Biosystems QuantStudio 5 Real-Time PCR system for human identification. The system is designed to deliver efficient performance with a smaller footprint and lower annual maintenance costs, the company said. It has been optimized with the new HID Real-Time PCR Analysis Software v1.3, which allows researcher to perform data analysis with a virtual standard curve feature to minimize variation and reduce costs associated with using standards on every plate. The software also includes quantification and short tandem repeat setup features.
Myriad Genetics EndoPredict Test
Myriad Genetics has launched the EndoPredict test, a second-generation test for assessing the 10-year risk of disease recurrence in patients with ER+ HER2- early-stage breast cancer. The test includes proliferation-related genes and hormone receptor-related genes to provide clinicians with an accurate assessment of early and late risk recurrence, the company said. It uses this information to definitively classify patients as low or high risk, which helps clinicians make therapy decisions going forward.
Asuragen AmplideX PCR/CE TOMM40 Kit
Asuragen has launched a kit in its AmplideX line to detect poly-T polymorphisms in the TOMM40 gene using PCR and capillary electrophoresis. The AmplideX PCR/CE TOMM40 Kit expands the firm's portfolio into the neurodegeneration, dementia progression, and Alzheimer’s disease research space. It builds on Asuragen's success with its FMR1 and C9orf72 kits, which also reveal definitive genotypes from repetitive DNA and overcome challenges associated with high homology sequences.
For more new products and services, please visit the New Products page on our website.